Physician

Hassan Baydoun, M.D.

According to 2025 Medicare claims, Hassan Baydoun, M.D. (NPI: 1538456256) practices cardiology in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is CARDIAC AND VASCULAR CONSULTANTS MD PA (NPI: 1093006108; TIN: 27-0363591) and primary practice location at 34461-9215.

Baydoun's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 729 traditional Medicare patients, billed 8,250 HCPCS/CPT codes, and received $788,053 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 4,340 prescription claims across 579 beneficiaries totaling $908,243 in drug costs, led by Eliquis (Apixaban). DME data shows 28 claims. Open Payments data shows 51 records totaling $1,424. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $185,692 to $788,053. Similarly, Part D prescription costs have moved sharply higher in recent years, from $13,402 to $908,243. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	540	2,057	$185,692
2019	1,287	7,353	$586,404
2020	1,251	7,316	$600,334
2021	1,169	8,293	$590,649
2022	936	7,650	$651,880
2023	986	7,002	$598,238
2024	729	8,250	$788,053

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	331	$13,402
2016	38	246	$8,850
2017	21	109	$5,290
2018	33	134	$5,497
2019	133	823	$70,350
2020	329	1,603	$175,083
2021	415	2,640	$320,450
2022	451	3,331	$549,519
2023	518	3,756	$765,573
2024	579	4,340	$908,243

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	56	$6,745
2024	N/R	28	$4,308

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	180	180	$277
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	438	1,286	$99
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	231	233	$96
93017	Exercise or drug-induced heart stress test with electrocardiogram (ecg)	156	156	$23
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	203	232	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	276	15,007	$281,234
Xarelto	Rivaroxaban	176	9,755	$173,549
Entresto	Sacubitril/Valsartan	126	6,990	$153,200
Farxiga	Dapagliflozin Propanediol	72	3,400	$60,951
Brilinta	Ticagrelor	72	4,152	$60,397

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	14	$3,614
J2260	Injection, milrinone lactate, 5 mg	N	N/R	14	$694

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$1,424	Inari Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hassan Baydoun, M.D.?

Tedicare shows public-source Medicare data for Hassan Baydoun, M.D. (NPI 1538456256), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hassan Baydoun, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hassan Baydoun, M.D.?

Hassan Baydoun, M.D. is linked to CARDIAC AND VASCULAR CONSULTANTS MD PA (billing NPI 1093006108) in the available physician profile data.

Does Hassan Baydoun, M.D. have Open Payments data?

Hassan Baydoun, M.D. has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.